scholarly journals Luminescent platinum(ii) complexes with self-assembly and anti-cancer properties: hydrogel, pH dependent emission color and sustained-release properties under physiological conditions

2015 ◽  
Vol 6 (7) ◽  
pp. 3823-3830 ◽  
Author(s):  
Johnson Lui-Lui Tsai ◽  
Taotao Zou ◽  
Jia Liu ◽  
Tianfeng Chen ◽  
Anna On-Yee Chan ◽  
...  

Luminescent platinum(ii) complexes show anti-cancer and pH-dependent self-assembly and sustained-release properties under physiological conditions.

Pharmaceutics ◽  
2021 ◽  
Vol 13 (6) ◽  
pp. 904
Author(s):  
Irin Tanaudommongkon ◽  
Asama Tanaudommongkon ◽  
Xiaowei Dong

Most antiretroviral medications for human immunodeficiency virus treatment and prevention require high levels of patient adherence, such that medications need to be administered daily without missing doses. Here, a long-acting subcutaneous injection of lopinavir (LPV) in combination with ritonavir (RTV) using in situ self-assembly nanoparticles (ISNPs) was developed to potentially overcome adherence barriers. The ISNP approach can improve the pharmacokinetic profiles of the drugs. The ISNPs were characterized in terms of particle size, drug entrapment efficiency, drug loading, in vitro release study, and in vivo pharmacokinetic study. LPV/RTV ISNPs were 167.8 nm in size, with a polydispersity index of less than 0.35. The entrapment efficiency was over 98% for both LPV and RTV, with drug loadings of 25% LPV and 6.3% RTV. A slow release rate of LPV was observed at about 20% on day 5, followed by a sustained release beyond 14 days. RTV released faster than LPV in the first 5 days and slower than LPV thereafter. LPV trough concentration remained above 160 ng/mL and RTV trough concentration was above 50 ng/mL after 6 days with one subcutaneous injection. Overall, the ISNP-based LPV/RTV injection showed sustained release profiles in both in vitro and in vivo studies.


Soft Matter ◽  
2021 ◽  
Vol 17 (11) ◽  
pp. 3096-3104
Author(s):  
Valeria Castelletto ◽  
Jani Seitsonen ◽  
Janne Ruokolainen ◽  
Ian W. Hamley

A designed surfactant-like peptide is shown, using a combination of cryogenic-transmission electron microscopy and small-angle X-ray scattering, to have remarkable pH-dependent self-assembly properties.


Polyhedron ◽  
2008 ◽  
Vol 27 (12) ◽  
pp. 2672-2680 ◽  
Author(s):  
Zhao-Peng Qi ◽  
Zheng-Shuai Bai ◽  
Qing Yuan ◽  
Taka-aki Okamura ◽  
Kai Cai ◽  
...  

Molecules ◽  
2021 ◽  
Vol 26 (10) ◽  
pp. 2846
Author(s):  
Seung Hyuk Im ◽  
Dam Hyeok Im ◽  
Su Jeong Park ◽  
Justin Jihong Chung ◽  
Youngmee Jung ◽  
...  

Polylactide (PLA) is among the most common biodegradable polymers, with applications in various fields, such as renewable and biomedical industries. PLA features poly(D-lactic acid) (PDLA) and poly(L-lactic acid) (PLLA) enantiomers, which form stereocomplex crystals through racemic blending. PLA emerged as a promising material owing to its sustainable, eco-friendly, and fully biodegradable properties. Nevertheless, PLA still has a low applicability for drug delivery as a carrier and scaffold. Stereocomplex PLA (sc-PLA) exhibits substantially improved mechanical and physical strength compared to the homopolymer, overcoming these limitations. Recently, numerous studies have reported the use of sc-PLA as a drug carrier through encapsulation of various drugs, proteins, and secondary molecules by various processes including micelle formation, self-assembly, emulsion, and inkjet printing. However, concerns such as low loading capacity, weak stability of hydrophilic contents, and non-sustainable release behavior remain. This review focuses on various strategies to overcome the current challenges of sc-PLA in drug delivery systems and biomedical applications in three critical fields, namely anti-cancer therapy, tissue engineering, and anti-microbial activity. Furthermore, the excellent potential of sc-PLA as a next-generation polymeric material is discussed.


2017 ◽  
Vol 18 (3) ◽  
pp. 943-950 ◽  
Author(s):  
Muhammad Waqas ◽  
Woo-jin Jeong ◽  
Young-Joo Lee ◽  
Dae-Hwan Kim ◽  
Chongsuk Ryou ◽  
...  

2019 ◽  
Vol 11 (37) ◽  
pp. 33573-33580 ◽  
Author(s):  
Valeria Castelletto ◽  
Charlotte J. C. Edwards-Gayle ◽  
Francesca Greco ◽  
Ian W. Hamley ◽  
Jani Seitsonen ◽  
...  

2019 ◽  
Vol 17 (18) ◽  
pp. 4543-4553 ◽  
Author(s):  
Jessica A. Hutchinson ◽  
Ian W. Hamley ◽  
Charlotte J. C. Edwards-Gayle ◽  
Valeria Castelletto ◽  
Cristian Piras ◽  
...  

The self-assembly of a palmitoylated peptide C16-EELNRYY based on a fragment of the gut hormone peptide PYY3–36 is investigated.


2021 ◽  
Vol 9 (1) ◽  
pp. 116-123
Author(s):  
Jindao Wu ◽  
Wenzhou Ding ◽  
Guoyong Han ◽  
Wei You ◽  
Wen Gao ◽  
...  

Nanomedicines generally suffer from poor accumulation in tumor cells, low anti-tumor efficacy, and drug resistance. In order to address these problems, we introduced a novel nanomedicine based on dual anti-cancer drugs, which showed good cell nuclear accumulation properties.


Sign in / Sign up

Export Citation Format

Share Document